Neurology Edition: Top Headlines for Week of September 5, 2022

In this edition, blood-based concussion diagnostic tool gets patent; examining the brain’s electrical signals may be key to treating epilepsy, schizophrenia; machine-learning model may predict best antiseizure medications and more.

Read the full coverage here:

Neurolytixs secures US patent for blood-based concussion diagnostic tool

Examination of brain’s electrical signals may be key to treating epilepsy, schizophrenia

Machine-learning model may predict which antiseizure medications work best

Rafa receives FDA approval for autoinjector to treat status epilepticus in adults

Aptinyx completes enrollment of phase 2 trial for oral cognitive impairment treatment

References:

Hakeem H, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.2514.

Press Release

Press Release

Press Release

Press Release